Dysregulated TRIM expression or activity contributes to the pathogenesis of autoimmune diseases, including SLE, Sjögren's syndrome, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, and type I diabetes. This evidence concerns the gene TRAT1 and type 1 diabetes mellitus.